More News

16 Jun 2020 Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
16 Jun 2020 IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
15 Jun 2020 Magenta Therapeutics and Beam Therapeutics Announce Collaboration to Evaluate Targeted Antibody-Drug Conjugate (ADC) MGTA-117 as Conditioning Regimen for Base Editing Therapies
13 Jun 2020 CRISPR Therapeutics and Vertex Announce New Clinical Data for Investigational Gene-Editing Therapy CTX001™ in Severe Hemoglobinopathies at the 25th Annual European Hematology Association (EHA) Congress
11 Jun 2020 Egle Therapeutics Enters Into a Corporate Strategic Research Alliance with Takeda to Uncover Novel Tumor-specific Regulatory T-cell Targets and Develop Unique Anti-Suppressor-Based Immunotherapies
11 Jun 2020 Novo Nordisk to acquire Corvidia Therapeutics and expand presence in cardiovascular disease
10 Jun 2020 Debiopharm's Novel Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
10 Jun 2020 Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collaboration and License Agreement With Lilly
09 Jun 2020 CSL Behring to Acquire Biotech Company Vitaeris
05 Jun 2020 Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
05 Jun 2020 UCB acquires Engage Therapeutics: Staccato® Alprazolam - A potential solution for acute on-demand seizure management for people living with epilepsy
04 Jun 2020 Targovax Enters Collaboration With Leidos to add Checkpoint Inhibitor Functionality to ONCOS Viruses
04 Jun 2020 Ferring and Igenomix Collaborate to Advance Care in Reproductive Medicine and Maternal Health Ferring and Igenomix Collaborate to Advance Care in Reproductive Medicine and Maternal Health
04 Jun 2020 AstraZeneca to discover and develop novel therapies targeting RNA-modifying proteins in oncology collaboration with Accent Therapeutics
03 Jun 2020 Novellus Executes Exclusive Worldwide License Agreement with Plexxikon for PLX8394, Plexxikon’s Next-Generation, Clinical Stage BRAF Inhibitor
03 Jun 2020 Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement
01 Jun 2020 Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
01 Jun 2020 AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors
28 May 2020 EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer
28 May 2020 Sensei Biotherapeutics Completes Acquisition of Alvaxa Biosciences, a Camelid Antibody Therapeutics Company
27 May 2020 Gilead Sciences and Arcus Biosciences Establish 10-year Partnership to Co-develop and Co-commercialize Next-generation Cancer Immunotherapies
27 May 2020 Repare Therapeutics Announces Multi-Target Discovery Collaboration with Bristol Myers Squibb
26 May 2020 Tetra Therapeutics Enters Into Definitive Merger Agreement To Be Acquired by Shionogi
26 May 2020 Merck to Acquire Themis
26 May 2020 Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up